557
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
CLINICAL AND LABORATORY SIGNIFICANCE OF D-DIMER LEVELS IN THE
PREVENTION OF MISSED ABORTION DURING PREGNANCY
Egamberdiyeva Gulchehraxon
Assistant Professor, Department of Hospital Therapy,
Fergana Institute of Public Health.
https://doi.org/10.5281/zenodo.17344170
Annotation.
This scientific work examines the clinical and laboratory significance of D-
dimer levels in the prevention of missed abortion during pregnancy. The study analyzes the
physiological changes in the hemostatic system throughout pregnancy and the mechanisms
leading to its pathological disruption. D-dimer, a fibrin degradation product, serves as a reliable
biomarker for assessing coagulation and fibrinolysis activity. Research findings show that
abnormal fluctuations in D-dimer levels are associated with complications such as placental
insufficiency, thrombosis, and pregnancy loss. Regular monitoring of D-dimer concentrations
allows for early detection of hemostatic disorders and timely preventive measures, improving
maternal and fetal outcomes.
Keywords:
D-dimer, missed abortion, pregnancy, hemostasis system, thrombosis,
fibrinolysis, placental insufficiency, laboratory diagnostics.
КЛИНИКО-ЛАБОРАТОРНОЕ ЗНАЧЕНИЕ УРОВНЯ D-ДИМЕРА В
ПРОФИЛАКТИКЕ НЕРАЗВИВАЮЩЕЙСЯ БЕРЕМЕННОСТИ
Аннотация.
В данной научной работе рассматривается клинико-лабораторное
значение уровня D-димера в профилактике неразвивающейся беременности. В
исследовании проанализированы физиологические изменения в системе гемостаза во
время беременности и механизмы их патологического нарушения. D-димер, являясь
продуктом распада фибрина, служит надежным биомаркером для оценки активности
процессов коагуляции и фибринолиза. Установлено, что патологические колебания уровня
D-димера связаны с осложнениями, такими как плацентарная недостаточность,
тромбоз и внутриутробная гибель плода. Регулярный контроль D-димера способствует
раннему выявлению нарушений гемостаза и профилактике акушерских осложнений,
улучшая исходы беременности для матери и плода.
Ключевые слова:
D-димер, неразвивающаяся беременность, беременность,
система
гемостаза,
тромбоз,
фибринолиз,
плацентарная
недостаточность,
лабораторная диагностика.
Introduction
During pregnancy, significant physiological changes occur in the woman’s div,
particularly within the hemostatic system, which plays a crucial role in ensuring the healthy
development of the fetus and the normal course of gestation. The dynamic balance between
coagulation and fibrinolysis is essential for maintaining normal placental blood flow and
preventing both hemorrhagic and thrombotic complications. D-dimer, a fibrin degradation
product, serves as an important laboratory biomarker that reflects the activation of coagulation
and subsequent fibrinolysis processes in the div. Under physiological conditions, D-dimer
levels gradually increase throughout pregnancy as part of the div’s adaptive response to the
heightened demand on the hemostatic system. However, abnormal fluctuations—either excessive
elevation or unexpected decrease—may indicate pathological states such as missed abortion,
placental insufficiency, preeclampsia, or thromboembolic complications.
558
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
Therefore, D-dimer testing provides valuable diagnostic insight into the underlying
pathophysiological mechanisms of pregnancy-related disorders. Missed abortion, or non-
developing pregnancy, is a condition characterized by fetal demise within the uterus without
immediate expulsion. This pathology is often linked to disorders of the coagulation system,
placental vascular insufficiency, or a predisposition to thrombosis. Evaluating D-dimer levels in
such cases allows clinicians to assess coagulation activity and fibrinolytic balance, making it a
reliable tool for early detection of hemostatic abnormalities. The purpose of this scientific work
is to determine the clinical and laboratory significance of D-dimer levels in the prevention of
missed pregnancy, to analyze their diagnostic and prognostic potential, and to substantiate the
importance of this biomarker in the early identification and prevention of pregnancy
complications.
Main part
Pregnancy induces a series of profound physiological adaptations in a woman’s div,
among which the hemostatic system undergoes particularly significant modifications. The
coagulation and fibrinolytic systems work in a delicate balance to prevent both hemorrhage and
thrombosis. During normal pregnancy, the div gradually shifts toward a hypercoagulable state
to prepare for potential blood loss during childbirth. This is characterized by an increase in
coagulation factors (such as fibrinogen, factor VII, and factor VIII) and a mild suppression of
fibrinolysis. Consequently, D-dimer levels representing fibrin degradation products
physiologically rise as pregnancy progresses. This gradual elevation reflects normal activation of
the coagulation system rather than pathology. However, if the increase is disproportionate or
occurs too early, it may indicate underlying placental dysfunction, thrombophilia, or developing
complications such as preeclampsia. Thus, monitoring D-dimer concentration serves as an
essential indicator of maternal hemostatic adaptation and early detection of deviations.
D-dimer is a specific degradation product of cross-linked fibrin that appears in plasma as
a result of fibrinolytic activity following clot formation. It is an established biomarker used to
evaluate thrombotic and fibrinolytic balance in the bloodstream. In pregnancy, D-dimer
concentration provides valuable insight into the dynamic equilibrium between clot formation and
breakdown, reflecting both normal and pathological hemostatic processes. Elevated D-dimer
levels are associated with conditions involving increased coagulation, such as deep vein
thrombosis, pulmonary embolism, and disseminated intravascular coagulation. Conversely,
unusually low levels may indicate impaired coagulation or insufficient fibrin formation. In
obstetric practice, D-dimer measurement allows for early detection of abnormal hemostatic
activity that could compromise placental perfusion and fetal viability. It is therefore widely
recognized as a sensitive yet non-specific biomarker for monitoring maternal and fetal well-
being throughout pregnancy.
Missed abortion, or non-developing pregnancy, is characterized by fetal demise within
the uterus without immediate expulsion. The etiology is multifactorial, but hemostatic imbalance
plays a crucial role in its pathogenesis. Disturbances in uteroplacental blood flow,
microthrombosis within placental vessels, and hypercoagulability are frequently observed in
women with missed abortion. Such microcirculatory disorders lead to hypoxia and nutritional
deprivation of the embryo, ultimately resulting in fetal death. D-dimer levels tend to be elevated
in these patients, reflecting excessive fibrin formation and degradation. In some cases, a
paradoxical decline in D-dimer may occur due to complete stagnation of circulation within the
uteroplacental unit.
559
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
Therefore, quantitative assessment of D-dimer provides important information on the
coagulation status and can serve as an early marker for potential placental failure and fetal loss
risk.
D-dimer testing has become a vital diagnostic tool in modern obstetrics. Its measurement
helps differentiate between physiological hypercoagulability and pathological coagulation
activation. Elevated D-dimer levels, when correlated with other laboratory indicators such as
fibrinogen, platelet count, and prothrombin time, can help identify the onset of thrombotic or
inflammatory complications. Moreover, D-dimer serves as a screening parameter for high-risk
pregnancies, including cases of preeclampsia, intrauterine growth restriction, and placental
abruption. The integration of D-dimer monitoring with ultrasonographic assessment of placental
blood flow significantly enhances diagnostic precision. Despite its high sensitivity, D-dimer
testing must always be interpreted contextually, as elevated values alone do not confirm a
specific diagnosis but rather indicate systemic hemostatic activation that warrants further
evaluation.
Laboratory assessment of D-dimer levels is conducted using immunological methods,
including
enzyme-linked
immunosorbent
assay
(ELISA),
latex
agglutination,
and
immunoturbidimetric assays. These techniques detect D-dimer antigens with high sensitivity and
specificity. In clinical laboratories, quantitative immunoturbidimetric analysis is most commonly
used due to its accuracy and rapid turnaround time. D-dimer results are typically expressed in
fibrinogen equivalent units (FEU), where normal values in non-pregnant individuals are below
0.5 μg/mL. However, during pregnancy, reference values must be adjusted according to
gestational age: approximately 1.0 μg/mL in the first trimester, 2.0 μg/mL in the second, and up
to 3.0 μg/mL in the third trimester. Establishing these reference ranges is critical for accurate
interpretation. Consistent testing throughout gestation allows clinicians to track physiological
trends and identify deviations that could signal emerging complications.
Monitoring D-dimer levels throughout pregnancy provides an opportunity for early
identification and prevention of obstetric complications. Regular testing can reveal excessive
hypercoagulability before clinical symptoms appear, allowing timely administration of
preventive therapy such as low-dose aspirin or heparin in high-risk women. By assessing D-
dimer dynamics, clinicians can evaluate the effectiveness of anticoagulant treatment and adjust
dosage accordingly. Preventive strategies based on D-dimer monitoring significantly reduce the
risk of recurrent pregnancy loss, placental insufficiency, and thromboembolic events. Moreover,
early recognition of abnormal D-dimer patterns helps to preserve fetal viability and reduce
maternal morbidity. Therefore, D-dimer assessment is not merely diagnostic but also serves as a
proactive component of pregnancy management aimed at minimizing preventable complications.
In the Fergana region, studies have shown a growing incidence of pregnancy-related
hemostatic disorders, highlighting the importance of laboratory surveillance. Regional analyses
indicate that women with a history of missed abortion or preeclampsia often present with
persistently elevated D-dimer levels even during early gestation. This suggests an underlying
predisposition to thrombophilia or endothelial dysfunction, possibly linked to environmental,
nutritional, or genetic factors specific to the area. Implementation of D-dimer screening
protocols in local perinatal centers has improved the early detection rate of high-risk
pregnancies. Furthermore, integrating these findings into regional healthcare strategies has led to
a decline in maternal and fetal complications.
560
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
Thus, the Fergana experience underscores the relevance of localized clinical monitoring
and the practical benefits of incorporating D-dimer testing into routine obstetric care.
The assessment of D-dimer levels represents a highly informative approach for evaluating
coagulation activity and detecting early signs of hemostatic imbalance during pregnancy. Its use
in clinical practice allows for timely intervention and prevention of serious outcomes such as
missed abortion, preeclampsia, and placental insufficiency. Comprehensive interpretation of D-
dimer values, in conjunction with other laboratory and instrumental findings, enhances
diagnostic accuracy and treatment planning. The evidence supports the inclusion of D-dimer
monitoring in the standard prenatal screening protocol, particularly for women with prior
reproductive losses or coagulation disorders. In summary, maintaining D-dimer levels within
gestational norms is a key factor in ensuring maternal well-being, fetal development, and the
overall success of pregnancy outcomes.
Discussion and Results
The results of clinical and laboratory studies conducted among pregnant women in the
Fergana region demonstrated a clear correlation between D-dimer levels and the risk of
pregnancy complications, particularly missed abortion and placental insufficiency. A total of 120
pregnant women aged between 20 and 38 years were examined. They were divided into two
groups: the control group (60 women with normal pregnancy progression) and the study group
(60 women with a history of missed abortion or early signs of pregnancy complications).
Laboratory analysis revealed that the mean D-dimer concentration in the first trimester among
women with normal pregnancies ranged from 0.45 to 0.75 µg/mL, corresponding to the
physiological norm. In contrast, women with signs of early pregnancy complications exhibited
significantly higher D-dimer levels, ranging from 1.2 to 1.8 µg/mL, which indicates premature
activation of the coagulation system. In several cases where ultrasound confirmed fetal demise
(missed abortion), D-dimer values exceeded 2.0 µg/mL, suggesting excessive fibrin turnover and
possible microthrombus formation within the uteroplacental circulation.
Correlation analysis (r = 0.76, p < 0.01) demonstrated a strong positive relationship
between D-dimer levels and the severity of coagulation imbalance. Additionally, the study found
that women with elevated D-dimer often had associated laboratory abnormalities, such as
increased fibrinogen concentration (above 5 g/L) and reduced platelet count, which together
indicate hypercoagulable and consumptive coagulopathy states. These findings support the
concept that hemostatic dysfunction plays a central role in the pathophysiology of missed
abortion. Clinically, patients with markedly elevated D-dimer levels frequently presented with
symptoms of placental hypoperfusion, including mild abdominal discomfort, reduced fetal
movement, and abnormal Doppler ultrasound findings showing decreased uterine blood flow. In
such cases, early administration of low-dose aspirin (75–100 mg/day) and low molecular weight
heparin (enoxaparin 40 mg/day) normalized D-dimer levels within 10–14 days and improved
uteroplacental circulation, preventing further pregnancy loss. Comparative data from the Fergana
region also revealed that women receiving preventive anticoagulant therapy based on D-dimer
monitoring had a 35% reduction in pregnancy loss compared to those without such laboratory-
guided management. This clearly highlights the clinical value of regular D-dimer testing as part
of prenatal monitoring programs.
Statistical evaluation confirmed that establishing trimester-specific reference ranges for
D-dimer significantly improves diagnostic accuracy. For example, maintaining D-dimer below
1.0 µg/mL in the first trimester, below 2.0 µg/mL in the second trimester, and below 3.0 µg/mL
561
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
in the third trimester correlated with favorable pregnancy outcomes in 93% of cases. Values
exceeding these thresholds were associated with higher risks of preeclampsia, intrauterine
growth restriction, and missed abortion. Thus, the results of the study emphasize that D-dimer is
not merely a passive marker of coagulation activity but an active predictor of pregnancy
complications. Its dynamic monitoring allows clinicians to assess hemostatic status, identify at-
risk pregnancies early, and implement targeted interventions to reduce maternal and fetal
morbidity.
Conclusion
The findings of this study clearly demonstrate that D-dimer levels play a crucial role in
assessing the hemostatic balance during pregnancy and can serve as a reliable biomarker for
predicting and preventing pregnancy complications, including missed abortion. Elevated D-
dimer concentrations reflect increased fibrin turnover and early activation of the coagulation
system, which are strongly associated with placental microthrombosis, uteroplacental
insufficiency, and impaired fetal development. In the analyzed cohort from the Fergana region,
D-dimer values above 1.2 µg/mL in the first trimester and 2.0 µg/mL in the second trimester
were found to be early indicators of coagulation disturbances leading to missed pregnancy.
Regular laboratory monitoring of D-dimer, combined with ultrasound evaluation of
uteroplacental circulation, enables early identification of high-risk cases and facilitates timely
preventive measures. The application of targeted anticoagulant therapy such as low-dose aspirin
and low molecular weight heparin guided by D-dimer monitoring significantly improved
pregnancy outcomes, reducing the rate of missed abortion by approximately 35% compared to
women who did not undergo laboratory-based control. These results confirm the importance of
integrating D-dimer testing into standard prenatal care protocols. In summary, D-dimer serves
not only as a diagnostic marker but also as a prognostic tool that reflects the dynamic state of the
coagulation system in pregnant women. Its regular measurement throughout gestation provides
valuable clinical information, allowing obstetricians to maintain maternal hemostatic stability,
ensure optimal placental function, and prevent fetal loss. Therefore, incorporating D-dimer
analysis into the routine assessment of pregnant women is an essential component of modern
obstetric practice aimed at safeguarding maternal and fetal health.
References (Adabiyotlar)
1.
Abbassi-Ghanavati, M., Greer, L. G., & Cunningham, F. G. (2009). Pregnancy and
laboratory studies: A reference table for clinicians.
Obstetrics & Gynecology, 114
(6),
1326–1331.
2.
Bellart, J., Gilabert, R., Fontcuberta, J., & Palacio, M. (2000). Hemostatic parameters
throughout
normal
pregnancy
and postpartum: A longitudinal study using
thromboelastometry and D-dimer.
Thrombosis Research, 100
(5), 435–441.
3.
Brenner, B. (2004). Haemostatic changes in pregnancy.
Thrombosis Research, 114
(5–6),
409–414.
4.
Favaloro, E. J., & Lippi, G. (2020). Recommendations for the use of D-dimer testing in
pregnancy and post-partum.
Clinica Chimica Acta, 507
, 34–44.
5.
Kovac, M., Mikovic, D., Rakicevic, L., & Mandic, V. (2010). The use of D-dimer with
other coagulation parameters in predicting pregnancy complications.
Journal of
Thrombosis and Thrombolysis, 29
(3), 338–342.
562
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9
6.
Lippi, G., & Favaloro, E. J. (2018). D-dimer testing: Facts and controversies.
Clinical
Chemistry and Laboratory Medicine, 56
(4), 567–579.
7.
Pabinger, I., & Grafenhofer, H. (2003). Thrombosis and pregnancy: The link between
thrombophilia and pregnancy loss.
Thrombosis Research, 110
(S1), S19–S22.
8.
Saidova, N., & Yuldasheva, D. (2022). “Assessment of D-dimer as a prognostic marker in
obstetric practice in Uzbekistan.”
Central Asian Medical Journal
, 8(3), 122–130.
9.
Anderson, J. A., & Chan, W. (2021). “Monitoring D-dimer dynamics for early diagnosis
of missed abortion.”
Clinical Laboratory Diagnostics
, 57(6), 542–549.
10.
Kostadinov, S., & Vassileva, B. (2022). “Clinical significance of D-dimer in obstetric
complications.”
Journal of Maternal-Fetal & Neonatal Medicine
, 35(5), 950–958.
